Abstract
In a longitudinal study involving 100 Singaporean women, results indicate that the acceptors persist in having a possibly increased predisposition to thrombosis, as evidenced by a significant increase in platelet count and aggregability. Furthermore, the shortened prothrombin time and activated partial thromboplastin time, together with changes in vitamin K factors, still indicate the possible enhanced potential for hypercoagulation.
Resumé
Dans l'étude longitudinale effectuée sur 100 femmes singapouriennes, les résultats indiquent que celles-ci ont continué à présenter ce qui est peut-être une prédisposition accrue à la thrombose, ainsi que l'a fait ressortir l'augmentation significative du nombre de plaquettes et de leur possibilité d'agrégation. En outre, le raccourcissement du temps de prothrombine et l'accélération du temps de thromboplastine partielle associés aux changements des facteurs de la vitamine K indiquent encore la possibilité d'une élévation potentielle de l'hypercoagulation.
Resumen
En el estudio longitudinal efectuado con 100 mujeres de Singapur, los resultados indican que continúan presentando lo que puede ser una predisposición acrecentada a la trombosis, según lo señalado por un aumento significativo del número de plaquetas y su posible agregación. Por otra parte, el acortamiento del tiempo de protrombina y la aceleración del tiempo de tromboplastina parcial asociados con los cambios de los factores de la vitamina K continúan indicando la posibilidad de un aumento potencial de la hipercoagulación.
Similar content being viewed by others
References
Royal College of General Practitioners (1974).Oral Contraceptives and Health: A Preliminary Report. Pitman Medical Publishing Co., Ltd., New York
PollerL. (1978). Oral contraceptives, blood clotting and thrombosis.Br. Med. Bull.,34, 151
NoteloviyzM., KitchensC.S., CooneL., McKenzieL. and CarterR. (1981). Low-dose oral contraceptives; usage and coagulation.Am. J. Obstet. Gynecol.,141, 71–75
MargulisR., AmbrusJ.L., MinkL. and StrykerJ. (1965). Progestational agents and blood coagulation.Am. J. Obstet. Gynecol.,93, 161–166
BellerF.K. and BorgesR.F. (1967). Blood coagulation and fibrinolytic enzyme studies during cyclic and continuous application of progestational agents.Am. J. Obstet. Gynecol.,97, 448–459
PollerL., ThomsonJ.K., ThomasW. and WrayC. (1971). Blood clotting and platelet aggregation during oral progestogen contraception: a follow-up study.Br. Med. J.,27, 705
DensonK.W.E. (1972). Techniques appendix 2, pp. 609–636. In:Human Blood Coagulation, Haemostatis and Thrombosis, R.Biggs, ed., Blackwell Scientific Publications, London
ThomsonJ.M. (1970).A Practical Guide to Blood Coagulation and Haemostasis, pp.174. Churchill Livingstone, London
RatnoffO.D. and MenzieI. (1951). A new method for the determination of fibrinogen in small samples of plasma.J. Lab. Clin. Med.,37, 316–320
DensonK.W.E., BorettR. and BiggsR. (1971). The specific assay of prothrombin using the Taipan snake venom.Br. J. Haematol.,21, 219–226
BiggsP., EvelingJ. and RichardsG. (1955). The assay of antihaemophilic globulin activity.Br. J. Haematol.,1, 21
DensonK.W.E. (1961). The specific assay of Prower-Stuart Factor and Factor VII.Acta Haematol.,25, 105–120
BiggsR., DensonK.W.E., AkmanN., BorettR. and HaddonM.E. (1970). Antithrombin III, antifactor Xa and heparin.Br. J. Haematol.,19, 283–285
NilssonC.G. and HolmaP. (1981). Menstrual blood loss with contraceptive subdermal levonorgestrel implants.Fertil. Steril.,35, 304–306
KohC.L.S., TsakokF.H.M. and RatnamS.S. (1982). The influence of pH and pregnancy on the level of plasminogen activator activity as measured by the fibrin plate method.Singapore J. Obstet. Gynaecol.,13, 206–214
MerskeyC., KleinerG.J. and JohnsonA.J. (1966). Quantitative estimation of split products and fibrinogen in human serum: relation to diagnosis and treatment.Blood,28, 11–13
BornG.V.R. and CrossM.J. (1963). The aggregation of blood platelets.J. Physiol.,169, 178–195
LaurellC.B. (1965). Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.Anal. Biochem.,15, 45–52
SinghK., ViegasO., KohS., SinghP. and RatnamS.S. (1988). The effects of Norplant on clinical chemistry in Singapore acceptors after one year of use: haemostatic changes.Contraception,38 (3), 313–323
Singh, K., Viegas, O., Koh, S., Singh, P. and Ratnam, S.S. (1988). Two-year follow-up of changes in clinical chemistry in Singaporean Norplant acceptors: haemostatic changes.Contraception, (in press)
HirschJ. (1981). Blood test for the diagnosis of venous and arterial thrombosis.Blood,57, 1
ShaabanM.M., ElwanS.I., El-KabashM.Y., FarghalyS.A. and ThabetN. (1984). Effect of levonorgestrel contraceptive implants (Norplant) on blood coagulation.Contraception,30, 421–430
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Singh, K., Viegas, O.A.C. & Ratnam, S.S. A three-year evaluation of hemostatic function in Singaporean Norplant acceptors. Adv Contracept 6, 23–32 (1990). https://doi.org/10.1007/BF01849484
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01849484